Only the dopamine hypothesis in schizophrenia?
Valchár, M.
Ceskoslovenska Psychiatrie 83(2): 98-104
1987
ISSN/ISBN: 0069-2336 PMID: 3581265 Document Number: 300966
Document emailed within 1 workday
Related Documents
Sayed, Y.; Garrison, J.M. 1983: The dopamine hypothesis of schizophrenia and the antagonistic action of neuroleptic drugs--a review Psychopharmacology Bulletin 19(2): 283-288Wyatt, R.J. 1986: The dopamine hypothesis: variations on a theme (II) Psychopharmacology Bulletin 22(3): 923-927
Dalery, J.; D'Amato, T. 1992: Towards a neurodevelopmental hypothesis in schizophrenia L'Encephale 18(2): 155-156
Franck, N.; Georgieff, N. 2002: Neurodevelopmental hypothesis of schizophrenia La Revue du Praticien 52(11): 1202-1207
Kanba, S.; Kato, T. 2014: Microglial hypothesis of schizophrenia Nihon Shinkei Seishin Yakurigaku Zasshi 34(1): 11-13
Potvin, S.; Stip, E.; Roy, J.-Y. 2003: Schizophrenia and addiction: An evaluation of the self-medication hypothesis L'Encephale 29(3 Part 1): 193-203
Di Chiara, G.; Morelli, M. 1993: Dopamine-acetylcholine-glutamate interactions in the striatum. a working hypothesis Advances in Neurology 60: 102-106
Hashimoto, K.; Iyo, M. 2002: Glutamate hypothesis of schizophrenia and targets for new antipsychotic drugs Nihon Shinkei Seishin Yakurigaku Zasshi 22(1): 3-13
Itokawa, M.; Yoshikawa, T. 2003: Hypoglutamatergic hypothesis of schizophrenia: evidence from genetic studies Seishin Shinkeigaku Zasshi 105(11): 1349-1362
Kurachi, M.; Kawasaki, Y.; Suzuki, M. 2004: Generation of physiopathology of schizophrenia--a hypothesis of temporal-frontal lobe 2-step development Seishin Shinkeigaku Zasshi 106(9): 1180-1185
Liégeois, J.; Eyrolles, L.; Bruhwyler, J.; Delarge, J. 1998: Dopamine D4 receptors: a new opportunity for research on schizophrenia Current Medicinal Chemistry 5(2): 77-100
Malmgren, H. 2007: The hypothesis about schizophrenia as a "brain disease" still remains to be proved. the classical view on psychogenetic basis not yet contradicted Lakartidningen 104(30-31): 2152-2155
Sandler, M.; Ruthven, C.R.; Goodwin, B.L.; King, G.S.; Pettit, B.R.; Reynolds, G.P.; Tyrer, S.P.; Weller, M.P.; Hirsch, S.R. 1978: Raised cerebrospinal fluid phenylacetic acid concentration: preliminary support for the phenylethylamine hypothesis of schizophrenia? Communications in Psychopharmacology 2(3): 199-202
Yao, J.; Wang, B.-J. 2014: Relationship between genetic polymorphism of dopamine receptor and schizophrenia and its forensic significance Fa Yi Xue Za Zhi 30(3): 202-206
Beramendi, V.; Alpert, M.; Guimón, J.; Friedhoff, A.; Gutiérrez, M. 1980: Controlled study of L-dopa in schizophrenia with reference to the theory of hypersensitivity of dopamine receptors Archivos de Neurobiologia 43(2): 107-124
Farley, I.J.; Shannak, K.S.; Hornykiewicz, O. 1980: Brain monoamine changes in chronic paranoid schizophrenia and their possible relation to increased dopamine receptor sensitivity Advances in Biochemical Psychopharmacology 21: 427-433
Pritchard, M.A.; Kola, I. 1999: The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in down syndrome Journal of Neural Transmission. Supplementum 57: 293-303
Baron, M.; Levitt, M.; Asnis, L.; Fein, M. 1983: Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity Biological Psychiatry 18(5): 579-582
Allen, E.; Pettigrew, A.; Frank, D.; Thompson, S.; Myers, C.; Yamashita, T.; Blumer, J.L. 1997: Alterations in dopamine clearance and catechol-O-methyltransferase activity by dopamine infusions in children Critical Care Medicine 25(1): 181-189
Shibata, O.; Yorozuya, Y.; Nagatani, A.; Shimada, M.; Haseba, S.; Gotoh, Y.; Honda, Y. 1986: Dopamine and norepinephrine concentrations in the human digestive tract following exogenous dopamine administration Masui. Japanese Journal of Anesthesiology 35(12): 1830-1835